Chinese Journal of Oral Implantology ›› 2025, Vol. 30 ›› Issue (1): 91-96.DOI: 10.12337/zgkqzzxzz.2025.02.016
• Reviews • Previous Articles
Li Meiqi, Sun Xiaolin, Wang Lin
Received:
2024-11-06
Online:
2025-02-28
Published:
2025-02-24
Contact:
Sun Xiaolin, Email: sxl2673366@126.com, Tel: 0086-431-88796025; Wang Lin, Email: wanglin1982@jlu.edu.cn, Tel: 0086-431-88796025
Supported by:
Li Meiqi, Sun Xiaolin, Wang Lin. Application of probiotics in the management of peri-implant diseases[J]. Chinese Journal of Oral Implantology, 2025, 30(1): 91-96.
Add to citation manager EndNote|Ris|BibTeX
URL: https://zgkqzzxzz.cndent.com/EN/10.12337/zgkqzzxzz.2025.02.016
[1] Monje A, Salvi GE.Diagnostic methods/parameters to monitor peri-implant conditions[J]. Periodontol 2000, 2024,95(1):20-39. DOI: 10.1111/prd.12584. [2] Saleh M, Dias DR, Kumar P.The economic and societal impact of periodontal and peri-implant diseases[J]. Periodontol 2000, 2024.DOI: 10.1111/prd.12568.[published online ahead of print]. [3] Rokaya D, Srimaneepong V, Wisitrasameewon W, et al.Peri-implantitis update: risk indicators, diagnosis, and treatment[J]. Eur J Dent, 2020,14(4):672-682. DOI: 10.1055/s-0040-1715779. [4] Hosseini Hooshiar M, Mozaffari A, Hamed Ahmed M, et al.Potential role of metal nanoparticles in treatment of peri-implant mucositis and peri-implantitis[J]. Biomed Eng Online, 2024,23(1):101. DOI: 10.1186/s12938-024-01294-0. [5] Hosseini Hooshiar M, Badkoobeh A, Kolahdouz S, et al.The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis[J]. J Nanobiotechnology, 2024,22(1):207. DOI: 10.1186/s12951-024-02472-x. [6] Bustamante M, Oomah BD, Mosi-Roa Y, et al.Probiotics as an adjunct therapy for the treatment of halitosis, dental caries and periodontitis[J]. Probiotics Antimicrob Proteins, 2020,12(2):325-334. DOI: 10.1007/s12602-019-9521-4. [7] Nguyen T, Brody H, Lin GH, et al.Probiotics, including nisin-based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases[J]. Periodontol 2000, 2020,82(1):173-185. DOI: 10.1111/prd.12324. [8] Hill C, Guarner F, Reid G, et al.Expert consensus document. the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Nat Rev Gastroenterol Hepatol, 2014,11(8):506-514. DOI: 10.1038/nrgastro.2014.66. [9] Xu J, Chen C, Gan S, et al.The potential value of probiotics after dental implant placement[J]. Microorganisms, 2023,11(7):1845. DOI: 10.3390/microorganisms11071845. [10] Barbagallo G, Monaca G, Gregorio FD, et al.Adjuvant effect of probiotics in the treatment of periodontal and peri-implant diseases[M]. Frontiers in Periodontology-New Directions and Emerging Therapies. London: IntechOpen, 2024. DOI: 10.5772/intechopen.1005784. [11] Berglundh T, Mombelli A, Schwarz F, et al.Etiology, pathogenesis and treatment of peri-implantitis: a european perspective[J]. Periodontol 2000, 2024. DOI: 10.1111/prd.12549.[published online ahead of print]. [12] Belibasakis GN.Microbiological and immuno-pathological aspects of peri-implant diseases[J]. Arch Oral Biol, 2014,59(1):66-72. DOI: 10.1016/j.archoralbio.2013.09.013. [13] Amato M, Di Spirito F, D'Ambrosio F, et al. Probiotics in periodontal and peri-implant health management: biofilm control, dysbiosis reversal, and host modulation[J]. Microorganisms, 2022,10(11):2289. DOI: 10.3390/microorganisms10112289. [14] 晏子衡, 胡晓芳, 吴新. 益生菌对口腔常见疾病的影响研究[J].口腔医学,2018,38(2):185-188. DOI: 10.13591/j.cnki.kqyx.2018.02.021. Yan ZH, Hu XF, Wu X.Effect of probiotics on common oral diseases[J]. Stomatology,2018,38(2):185-188. DOI: 10.13591/j.cnki.kqyx.2018.02.021. [15] Laleman I, Pauwels M, Quirynen M, et al.The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: a randomized pilot study[J]. Clin Oral Implants Res, 2020,31(1):84-92. DOI: 10.1111/clr.13555. [16] Argandoña Valdez RM, Ximenez-Fyvie LA, Caiaffa KS, et al.Antagonist effect of probiotic bifidobacteria on biofilms of pathogens associated with periodontal disease[J]. Microb Pathog, 2021,150:104657. DOI: 10.1016/j.micpath.2020.104657. [17] Vacca C, Contu MP, Rossi C, et al.In vitro interactions between Streptococcus intermedius and Streptococcus salivarius K12 on a titanium cylindrical surface[J]. Pathogens, 2020,9(12):1069. DOI: 10.3390/pathogens9121069. [18] Santana SI, Silva P, Salvador SL, et al.Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: a randomized controlled trial[J]. J Clin Periodontol, 2022,49(8):828-839. DOI: 10.1111/jcpe.13663. [19] Mulla M, Mulla M, Hegde S, et al.In vitro assessment of the effect of probiotic Lactobacillus reuteri on peri-implantitis microflora[J]. BMC Oral Health, 2021,21(1):408. DOI: 10.1186/s12903-021-01762-2. [20] Kang MS, Park GY.In vitro evaluation of the effect of oral probiotic Weissella cibaria on the formation of multi-species oral biofilms on dental implant surfaces[J]. Microorganisms, 2021,9(12):2482. DOI: 10.3390/microorganisms9122482. [21] Radaic A, Brody H, Contreras F, et al.Nisin and nisin probiotic disrupt oral pathogenic biofilms and restore their microbiome composition towards healthy control levels in a peri-implantitis setting[J]. Microorganisms, 2022,10(7):1336. DOI: 10.3390/microorganisms10071336. [22] Hojo K, Nagaoka S, Murata S, et al.Reduction of vitamin K concentration by salivary Bifidobacterium strains and their possible nutritional competition with porphyromonas gingivalis[J]. J Appl Microbiol, 2007,103(5):1969-1974. DOI: 10.1111/j.1365-2672.2007.03436.x. [23] Nagaoka S, Hojo K, Murata S, et al.Interactions between salivary Bifidobacterium adolescentis and other oral bacteria: in vitro coaggregation and coadhesion assays[J]. FEMS Microbiol Lett, 2008,281(2):183-189. DOI: 10.1111/j.1574-6968.2008.01092.x. [24] Özcelik S, Kuley E, Özogul F.Formation of lactic, acetic, succinic, propionic, formic and butyric acid by lactic acid bacteria[J]. LWT-Food Sci Technol, 2016, 73: 536-542. DOI: 10.1016/j.lwt.2016.06.066. [25] Lin X, Chen X, Chen Y, et al.The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans[J]. Oral Dis, 2015,21(1):e128-e134. DOI: 10.1111/odi.12257. [26] El Oirdi S, Lakhlifi T, Bahar AA, et al.Isolation and identification of Lactobacillus plantarum 4F, a strain with high antifungal activity, fungicidal effect, and biopreservation properties of food[J]. J Food Process Preserv, 2021, 45(6): e15517. DOI: 10.1111/jfpp.15517. [27] Darbandi A, Asadi A, Mahdizade Ari M, et al.Bacteriocins: properties and potential use as antimicrobials[J]. J Clin Lab Anal, 2022,36(1):e24093. DOI: 10.1002/jcla.24093. [28] Jansen PM, Abdelbary M, Conrads G.A concerted probiotic activity to inhibit periodontitis-associated bacteria[J]. PLoS One, 2021,16(3):e0248308. DOI: 10.1371/journal.pone.0248308. [29] Luan C, Yan J, Jiang N, et al.Leuconostoc mesenteroides LVBH107 antibacterial activity against Porphyromonas gingivalis and anti-inflammatory activity against P. gingivalis lipopolysaccharide-stimulated RAW 264.7 cells[J]. Nutrients, 2022,14(13):2584. DOI: 10.3390/nu14132584. [30] López-Valverde N, López-Valverde A, Blanco Rueda JA.The role of probiotic therapy on clinical parameters and human immune response in peri-implant diseases: a systematic review and meta-analysis of randomized clinical studies[J]. Front Immunol, 2024,15:1371072. DOI: 10.3389/fimmu.2024.1371072. [31] Alves CH, Russi KL, Rocha NC, et al.Host-microbiome interactions regarding peri-implantitis and dental implant loss[J]. J Transl Med, 2022,20(1):425. DOI: 10.1186/s12967-022-03636-9. [32] Hajishengallis G, Chavakis T, Lambris JD.Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy[J]. Periodontol 2000, 2020,84(1):14-34. DOI: 10.1111/prd.12331. [33] Lukic J, Chen V, Strahinic I, et al.Probiotics or pro-healers: the role of beneficial bacteria in tissue repair[J]. Wound Repair Regen, 2017,25(6):912-922. DOI: 10.1111/wrr.12607. [34] Reid G, Jass J, Sebulsky MT, et al.Potential uses of probiotics in clinical practice[J]. Clin Microbiol Rev, 2003,16(4):658-672. DOI: 10.1128/CMR.16.4.658-672.2003. [35] Invernici MM, Furlaneto F, Salvador SL, et al.Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients[J]. PLoS One, 2020,15(9):e0238425. DOI: 10.1371/journal.pone.0238425. [36] Knackstedt R, Knackstedt T, Gatherwright J.The role of topical probiotics on wound healing: a review of animal and human studies[J]. Int Wound J, 2020,17(6):1687-1694. DOI: 10.1111/iwj.13451. [37] Albuquerque-Souza E, Balzarini D, Ando-Suguimoto ES, et al.Probiotics alter the immune response of gingival epithelial cells challenged by porphyromonas gingivalis[J]. J Periodontal Res, 2019,54(2):115-127. DOI: 10.1111/jre.12608. [38] Nilsson AG, Sundh D, Bäckhed F, et al.Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial[J]. J Intern Med, 2018,284(3):307-317. DOI: 10.1111/joim.12805. [39] Ohlsson C, Engdahl C, Fåk F, et al.Probiotics protect mice from ovariectomy-induced cortical bone loss[J]. PLoS One, 2014,9(3):e92368. DOI: 10.1371/journal.pone.0092368. [40] Li J, Ho W, Liu C, et al.The role of gut microbiota in bone homeostasis[J]. Bone Joint Res, 2021,10(1):51-59. DOI: 10.1302/2046-3758.101.BJR-2020-0273.R1. [41] Sapra L, Shokeen N, Porwal K, et al.Bifidobacterium longum ameliorates ovariectomy-induced bone loss via enhancing anti-osteoclastogenic and immunomodulatory potential of regulatory B cells (bregs)[J]. Front Immunol, 2022,13:875788. DOI: 10.3389/fimmu.2022.875788. [42] Wu Y, Yang Y, Wang L, et al.Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism[J]. Front Endocrinol (Lausanne), 2023,14:1109296. DOI: 10.3389/fendo.2023.1109296. [43] D'Amelio P, Sassi F. Gut microbiota, immune system, and bone[J]. Calcif Tissue Int, 2018,102(4):415-425. DOI: 10.1007/s00223-017-0331-y. [44] Flichy-Fernández AJ, Ata-Ali J, Alegre-Domingo T, et al.The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial[J]. J Periodontal Res, 2015,50(6):775-785. DOI: 10.1111/jre.12264. [45] López-Valverde N, López-Valverde A, Blanco Rueda JA.The role of probiotic therapy on clinical parameters and human immune response in peri-implant diseases: a systematic review and meta-analysis of randomized clinical studies[J]. Front Immunol, 2024,15:1371072. DOI: 10.3389/fimmu.2024.1371072. [46] Riccia DN, Bizzini F, Perilli MG, et al.Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease[J]. Oral Dis, 2007,13(4):376-385. DOI: 10.1111/j.1601-0825.2006.01291.x. [47] Krasse P, Carlsson B, Dahl C, et al.Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri[J]. Swed Dent J, 2006,30(2):55-60. [48] Kang MS, Chung J, Kim SM, et al.Effect of Weissella cibaria isolates on the formation of Streptococcus mutans biofilm[J]. Caries Res, 2006,40(5):418-425. DOI: 10.1159/000094288. [49] Sargolzaei N, Arab H, Gerayeli M, et al.Evaluation of the topical effect of probiotic mouthwash in the treatment of patients with peri-implant mucositis[J]. J Long Term Eff Med Implants, 2022,32(1):85-91. DOI: 10.1615/JLongTermEffMedImplants.2021039490. [50] Galofré M, Palao D, Vicario M, et al.Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: a triple-blind randomized clinical trial[J]. J Periodontal Res, 2018,53(3):378-390. DOI: 10.1111/jre.12523. [51] Flichy-Fernández AJ, Ata-Ali J, Alegre-Domingo T, et al.The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial[J]. J Periodontal Res, 2015,50(6):775-785. DOI: 10.1111/jre.12264. [52] Santana SI, Silva P, Salvador SL, et al.Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: a randomized controlled trial[J]. J Clin Periodontol, 2022,49(8):828-839. DOI: 10.1111/jcpe.13663. [53] Alqahtani F, Alshaikh M, Mehmood A, et al.Efficacy of antibiotic versus probiotics as adjuncts to mechanical debridement for the treatment of peri-implant mucositis[J]. J Oral Implantol, 2022,48(2):99-104. DOI: 10.1563/aaid-joi-D-20-00259. [54] Parreira G, de Araújo Nobre MA, Moreira A, et al. Limosilactobacillus reuteri as an adjuvant in the treatment of peri-implant mucositis in total rehabilitation: an exploratory study[J]. Eur J Dent, 2024,18(2):610-618. DOI: 10.1055/s-0043-1777822. [55] Tada H, Masaki C, Tsuka S, et al.The effects of Lactobacillus reuteri probiotics combined with azithromycin on peri-implantitis: a randomized placebo-controlled study[J]. J Prosthodontic Res, 2018, 62(1): 89-96. DOI: 10.1016/j.jpor.2017.06.006. [56] Mendonça C, Marques D, Silveira J, et al.Effects of probiotic therapy on periodontal and peri-implant treatments: an umbrella review[J]. JDR Clin Trans Res, 2024:23800844241240474. DOI: 10.1177/23800844241240474.[published online ahead of print]. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||